Total Equity - Calithera Biosciences Inc (F:2CB) - Alpha Spread
C

Calithera Biosciences Inc
F:2CB

Watchlist Manager
Calithera Biosciences Inc
F:2CB
Watchlist
Price: 3.86 EUR -2.53% Market Closed
Market Cap: 1m EUR
Have any thoughts about
Calithera Biosciences Inc?
Write Note

Calithera Biosciences Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Calithera Biosciences Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
C
Calithera Biosciences Inc
F:2CB
Total Equity
$20.4m
CAGR 3-Years
-48%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$14.8B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$28.2B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
28%

See Also

What is Calithera Biosciences Inc's Total Equity?
Total Equity
20.4m USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Total Equity amounts to 20.4m USD.

What is Calithera Biosciences Inc's Total Equity growth rate?
Total Equity CAGR 5Y
-33%

Over the last year, the Total Equity growth was -58%. The average annual Total Equity growth rates for Calithera Biosciences Inc have been -48% over the past three years , -33% over the past five years .

Back to Top